DiscussierCRISPR Therapeutics
CRISPR Therapeutics is a gene-editing biotechnology company that developed Casgevy, the first FDA-approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia, in partnership with Vertex Pharmaceuticals. The company pipeline extends into oncology, regenerative medicine, and in vivo gene editing, representing potentially transformative treatments for previously incurable genetic diseases. Biotech-focused growth investors are drawn to CRISPR Therapeutics for ...